ITMCTR2100005416Not yet recruitingPhase 4
Clinical Study on the Effectiveness and Safety of Guanxinning Tablets on Coronary Heart Disease Complicated with Diabetic Nephropathy
Affiliated Hospital of Hangzhou Normal University0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •(1) Meet the diagnostic criteria of blood stasis syndrome of coronary heart disease (Diagnostic criteria of blood stasis syndrome of coronary heart disease);
- •(2) Meet the diagnostic criteria for diabetes (diabetes mellitus, DM) established by the ADA in 2020;
- •(3) Those who meet one of the following conditions (Chinese Guidelines for Clinical Diagnosis and Treatment of Diabetic Kidney Disease 2021):
- •?Random urinary albumin/creatinine ratio (UACR) = = CR or urinary albumin excretion rate (UAER) = = R white excretion rate (( sugar, and repeat check UACR or UACR within 3-6 months) UAER, 2 out of 3 times reached or exceeded the critical value.
- •?Estimate the glomerular filtration rate (eGFR) <60ml glomerular filtration rate (. Sugar 3m-2, more than 3 months.
- •?Kidney biopsy conforms to the pathological changes of diabetic kidney disease (DKD).
- •(4) Those aged =18 years, =, =years old;
- •(5) Subjects are informed and voluntarily sign an informed consent form.
Exclusion Criteria
- •(1) Does not meet the inclusion criteria;
- •(2) People with infection, fever, congestive heart failure, uncontrolled blood sugar and blood pressure, or urinary tract infection;
- •(3) Unwilling to cooperate and mentally ill patients;
- •(4) Patients with serious diseases such as heart, lung, brain, liver, kidney, hematopoietic system, etc.;
- •(5) ALT and AST are higher than 3 times the upper limit of the normal range;
- •(6) Patients who have participated in clinical trials of other drugs in the past month;
- •(7) Women who are pregnant or preparing to become pregnant or breast-feeding;
- •(8) Those who have a history of drug allergy or allergic physique and are allergic to multiple drugs;
- •(9) Other patients who do not meet the selection criteria as judged by the investigator.
Investigators
Similar Trials
Recruiting
Phase 4
Clinical study on the effectiveness and safety of wound healing after low anal fistulaarchosyrinxITMCTR2024000059Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
Recruiting
Phase 2
Clinical Study on Diabetes supplement in participants with diabetes.CTRI/2024/04/065001Emil Pharmaceutical Industries Private Limited,
Completed
Not Applicable
Clinical study for the safety and effectiveness of the use of Perfectha® Derm lidocaine in the treatment of medium wrinklesISRCTN20356582Sinclair Pharma70
Active, not recruiting
Not Applicable
Clinical study of the safety and effectiveness of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) as fillers in the treatment of lip thinness and wrinkles around the mouthISRCTN30768206Sinclair Pharma68